| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |